These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 712064)

  • 1. The effects of passive immunization with tumor-specific antiserum on the active immune response of mice to sublines of leukemia L1210.
    Carlson GA; Terres G
    J Immunol; 1978 Nov; 121(5):1752-9. PubMed ID: 712064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-induced killing in vivo of L1210/MTX-R cells quantitated in passively immunized mice with 131I-iododeoxyuridine-labeled cells and whole-body measurement of retained radioactivity.
    Carlson GA; Terres G
    J Immunol; 1976 Sep; 117(3):822-9. PubMed ID: 956654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of high-grade tumor-specific immunity in a host using a cytotoxic T-lymphocyte clone specific for a stable tumor antigen on murine leukemia L1210.
    Rahman SM; Kawashima K; Nakashima I; Nagase F
    Cancer Res; 1988 Nov; 48(22):6450-4. PubMed ID: 3263189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential tumor immunogenicity of L1210 and its sublines. I. Effect of an increased antigen density on tumor cell surfaces on primary B cell responses in vitro.
    Fuji H; Mihich E; Pressman D
    J Immunol; 1977 Sep; 119(3):983-6. PubMed ID: 330761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection for high immunogenicity in drug-resistant sublines of murine lymphomas demonstrated by plaque assay.
    Fuji H; Mihich E
    Cancer Res; 1975 Apr; 35(4):946-52. PubMed ID: 1090366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic cross-reactivity of antigen(s) induced by drug treatment in two leukemic sublines.
    Nicolin A; Bini A; Di Padova F; Goldin A
    J Immunol; 1976 May; 116(5):1347-9. PubMed ID: 58028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of the passive antibody-induced suppression of the humoral immune response of mice to surface antigens on human cells.
    Gadd SJ; Brogan MP; Ashman LK
    Immunology; 1985 Feb; 54(2):223-31. PubMed ID: 2578428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of interferon on the immune response of mice to immunization with the cells of transplantable leukemias and sarkomas].
    Skurkovich SV; Ol'shanskaia NV; Kalinina IA; Klinova EG; Eremkina EI
    Vopr Onkol; 1977; 23(9):44-50. PubMed ID: 910422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of a unique tumor-associated surface antigen on L1210 leukemia cells recognized by semisyngeneic antisera.
    Yokochi T; Kawashima K; Nakashima I; Nagase F; Isobe K; Nagura E; Yamada K; Miyadai T; Kimura Y
    Cancer Res; 1987 Feb; 47(4):1006-9. PubMed ID: 3542198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Specifics anti-tumor immunity induced by gene immunization with ectopic hCGbeta encoding gene].
    Wang LX; Wu J; Guan QD; Xiong SD
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):316-9. PubMed ID: 12921555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody-recognizing tumor-associated antigen of DBA/2 mouse lymphoma L1210 and its sublines.
    Fuji H
    Transplant Proc; 1980 Sep; 12(3):388-90. PubMed ID: 6784299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of specific immune responses by feeding protein antigens. II. Effects of prior passive and active immunization.
    Hanson DG; Vaz NM; Rawlings LA; Lynch JM
    J Immunol; 1979 Jun; 122(6):2261-6. PubMed ID: 448128
    [No Abstract]   [Full Text] [Related]  

  • 14. Adoptive immunotherapy in BALB-c times DBA-2 Cr F1 mice bearing an immunogenic subline of L1210 leukemia.
    Nicolin A; Canti G; Goldin A
    Cancer Res; 1974 Nov; 34(11):3044-8. PubMed ID: 4424774
    [No Abstract]   [Full Text] [Related]  

  • 15. Acceleration of allogeneic antitumor immunity with immune RNA in vitro and T-cell suppression by L1210 tumor bearer spleen cells.
    Miura T; Maekawa T; Kurashige S; Mitsuhashi S
    Cancer Res; 1981 Feb; 41(2):383-98. PubMed ID: 6160907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the immune response with antigen specific IgM antibody: a dual role.
    Wason WM
    J Immunol; 1973 May; 110(5):1245-52. PubMed ID: 4633296
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunoregulation by antigen/antibody complexes. I. Specific immunosuppression induced in vivo with immune complexes formed in antibody excess.
    Caulfield MJ; Shaffer D
    J Immunol; 1987 Jun; 138(11):3680-3. PubMed ID: 3584970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune mechanisms in leukemia: suppression of cellular immunity by drugs and x-irradiation.
    Martinez D; Lukasewycz OA; Murphy WH
    J Immunol; 1975 Sep; 115(3):724-9. PubMed ID: 1151076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis and reversal of the inhibition of cytophilic antibody receptors produced by antibody.
    Mitchell MS; Mokyr MB; Goldwater DJ
    Cancer Res; 1975 May; 35(5):1121-7. PubMed ID: 1078991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.